Dynavax Technologies
DVAX
#5488
Rank
โ‚น115.61 B
Marketcap
โ‚น984.61
Share price
-0.14%
Change (1 day)
-9.82%
Change (1 year)

Dynavax Technologies (DVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น37.09 Billion

According to Dynavax Technologies 's latest financial reports the company's total liabilities are โ‚น37.09 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dynavax Technologies - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น33.41 B7.01%
2023-12-31โ‚น31.22 B-6.81%
2022-12-31โ‚น33.50 B-44.9%
2021-12-31โ‚น60.80 B182.22%
2020-12-31โ‚น21.54 B11.57%
2019-12-31โ‚น19.30 B86.82%
2018-12-31โ‚น10.33 B741.52%
2017-12-31โ‚น1.22 B-11.74%
2016-12-31โ‚น1.39 B-29.14%
2015-12-31โ‚น1.96 B-18.04%
2014-12-31โ‚น2.39 B111.62%
2013-12-31โ‚น1.13 B-17.03%
2012-12-31โ‚น1.36 B-24.61%
2011-12-31โ‚น1.81 B25.71%
2010-12-31โ‚น1.44 B-29.61%
2009-12-31โ‚น2.04 B-42.84%
2008-12-31โ‚น3.57 B12.16%
2007-12-31โ‚น3.19 B202.52%
2006-12-31โ‚น1.05 B309.11%
2005-12-31โ‚น0.25 B-56.76%
2004-12-31โ‚น0.59 B-85.25%
2003-12-31โ‚น4.04 B-4.05%
2002-12-31โ‚น4.21 B76.26%
2001-12-31โ‚น2.39 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
โ‚น46.30 B 24.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น989.55 B 2,567.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.984 T 18,727.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น3.335 T 8,891.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น6.160 T 16,507.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚น5.513 T 14,761.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น10.402 T 27,941.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น2.932 T 7,806.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น7.243 T 19,426.73%๐Ÿ‡บ๐Ÿ‡ธ USA